awmsg logo



ferric carboxymaltose (Ferinject®)


Reference No. 785

Publication date:
07/09/2011


Appraisal information

ferric carboxymaltose (Ferinject®) 50 mg solution for injection/infusion


Company: Vifor Pharma UK Ltd
BNF category: Nutrition and blood
NMG meeting date: 09/06/2011
AWMSG meeting date: 13/07/2011
   
   
Submission Type: Full Submission
Status: Recommended with restrictions
Advice No: 1011
Ministerial ratification: 01/09/2011

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Ferric carboxymaltose (Ferinject®) is recommended as an option for use within NHS Wales for the treatment of patients with iron deficiency when oral iron preparations are ineffective or cannot be used. Ferric carboxymaltose (Ferinject®) should be restricted for use in non-haemodialysis patients only. AWMSG is of the opinion that Ferric carboxymaltose (Ferinject®) is not suitable for shared care within NHS Wales for the above indication.
Final Appraisal Recommendation (FAR)
Download
Clinical Expert (CE) Summary
Download